首页 > 最新文献

Turk Onkoloji Dergisi-Turkish Journal of Oncology最新文献

英文 中文
Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study 瑞非尼在GIST患者中的毒性管理和有效性:一项真实世界的研究
IF 0.3 Q4 Medicine Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3756
N. Paksoy
{"title":"Toxicity Management and Effectiveness of Regorafenib in Advance GIST Patients: A Real-world Study","authors":"N. Paksoy","doi":"10.5505/tjo.2022.3756","DOIUrl":"https://doi.org/10.5505/tjo.2022.3756","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71126977","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Can A Dedicated Multidisciplinary Tumor Board Improve Personalized Medicine for Patients in Interventional Oncology? A Large Retrospective Single-Center Experience 一个专门的多学科肿瘤委员会能改善介入肿瘤患者的个性化医疗吗?大型回顾性单中心体验
IF 0.3 Q4 Medicine Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.2819
R. Iezzi
{"title":"Can A Dedicated Multidisciplinary Tumor Board Improve Personalized Medicine for Patients in Interventional Oncology? A Large Retrospective Single-Center Experience","authors":"R. Iezzi","doi":"10.5505/tjo.2022.2819","DOIUrl":"https://doi.org/10.5505/tjo.2022.2819","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71125371","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Impairment of NK Cell Mediated Immune Surveillance Against Acute Myeloid Leukemia NK细胞介导的对急性髓性白血病免疫监视功能的损害
IF 0.3 Q4 Medicine Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.2883
M. Taha
{"title":"Impairment of NK Cell Mediated Immune Surveillance Against Acute Myeloid Leukemia","authors":"M. Taha","doi":"10.5505/tjo.2022.2883","DOIUrl":"https://doi.org/10.5505/tjo.2022.2883","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71125385","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
The Impact of Sex Hormone-Binding Globulin Levels on Thromboembolic Events at Patients with Advanced Stage Adenocarcinoma 性激素结合球蛋白水平对晚期腺癌患者血栓栓塞事件的影响
IF 0.3 Q4 Medicine Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3466
M. Bozkurt
{"title":"The Impact of Sex Hormone-Binding Globulin Levels on Thromboembolic Events at Patients with Advanced Stage Adenocarcinoma","authors":"M. Bozkurt","doi":"10.5505/tjo.2022.3466","DOIUrl":"https://doi.org/10.5505/tjo.2022.3466","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71125426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adaptations during the COVID-19 Outbreak in Radiotherapy Practice COVID-19爆发期间放疗实践中的适应
IF 0.3 Q4 Medicine Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3485
R. Mungmunpuntipantip
{"title":"Adaptations during the COVID-19 Outbreak in Radiotherapy Practice","authors":"R. Mungmunpuntipantip","doi":"10.5505/tjo.2022.3485","DOIUrl":"https://doi.org/10.5505/tjo.2022.3485","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71125583","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Theoretical Bases of the Influence of Radiation-induced Abscopal Effects on the Cardiovascular System 辐射诱发的体外效应对心血管系统影响的理论基础
IF 0.3 Q4 Medicine Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.s1003
E. Topkan
{"title":"Theoretical Bases of the Influence of Radiation-induced Abscopal Effects on the Cardiovascular System","authors":"E. Topkan","doi":"10.5505/tjo.2022.s1003","DOIUrl":"https://doi.org/10.5505/tjo.2022.s1003","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71126752","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardiotoxicity After the Lymphoma 淋巴瘤后的心脏毒性
IF 0.3 Q4 Medicine Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.s1007
A. Özen
{"title":"Cardiotoxicity After the Lymphoma","authors":"A. Özen","doi":"10.5505/tjo.2022.s1007","DOIUrl":"https://doi.org/10.5505/tjo.2022.s1007","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71126880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of MRONJ Risk and Associated Factors in Patients Receiving Antiresorptive and/or Antiangiogenic Drug Therapy: A Retrospective Cohort Study 在接受抗吸收和/或抗血管生成药物治疗的患者中评估MRONJ风险及相关因素:一项回顾性队列研究
IF 0.3 Q4 Medicine Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3359
Ömer Ekici
{"title":"Evaluation of MRONJ Risk and Associated Factors in Patients Receiving Antiresorptive and/or Antiangiogenic Drug Therapy: A Retrospective Cohort Study","authors":"Ömer Ekici","doi":"10.5505/tjo.2022.3359","DOIUrl":"https://doi.org/10.5505/tjo.2022.3359","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71125186","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Radiotherapy in Cancer Treatment During The Covid-19 Pandemic: One Year Results From Northeast Turkey 2019冠状病毒病大流行期间放疗治疗癌症:土耳其东北部一年的结果
IF 0.3 Q4 Medicine Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3463
Özlem Aynacı
OBJECTIVE The goal of this article was to assess the effects and consequences of strict measures in radiation oncology centers in northeastern Turkey during the coronavirus disease-2019 pandemic and to ensure that the reorganization of programs occurred without interruption to radiotherapy (RT). METHODS We retrospectively reviewed the records of 1063 patients (median age 63 years;range 3-93 years) who were treated in RI centers from March 2020 to March 2021. The study cohort was divided into two groups: Group A consisted of patients who received RT in the first 6 months and Group B comprised patients who received RT in the second 6 months. RESULTS The age distribution was similar in both groups. The analysis of the intent of treatment showed that 585 (55%) patients were treated with a radical intent in Group A, whereas only 478 (45%) were treated with a radical intent in Group B. Lung, breast, and genitourinary cancers were the most common cancer types in both periods. There was a significant decline in the number of female patients in Group B. Test results of 31 (2.9%) patients, 8 (25.8%) women and 23 (74.2%) men, who had nasopharyngeal swabs, were positive. CONCLUSION This study shows that oncology patients in our region are more worried about disease progression than the pandemic and insist on going to RT, especially during the first 6-month period when the pandemic was thought to be temporary. As a result of careful precautions, treatments in the clinics continued without contamination.
目的:评估2019冠状病毒病大流行期间土耳其东北部放射肿瘤学中心采取严格措施的效果和后果,并确保在不中断放疗(RT)的情况下进行方案重组。方法:我们回顾性回顾了2020年3月至2021年3月在RI中心接受治疗的1063例患者(中位年龄63岁,范围3-93岁)的记录。研究队列分为两组:A组为前6个月接受RT治疗的患者,B组为后6个月接受RT治疗的患者。结果两组患者年龄分布相似。治疗目的分析显示,a组有585例(55%)患者接受了根治性治疗,而b组只有478例(45%)患者接受了根治性治疗。在这两个时期,肺癌、乳腺癌和泌尿生殖系统癌是最常见的癌症类型。b组女性患者数量明显减少,鼻咽拭子检测阳性31例(2.9%),女性8例(25.8%),男性23例(74.2%)。结论本研究显示,本地区肿瘤患者更担心疾病进展而不是大流行,并坚持接受RT治疗,特别是在认为大流行是暂时的前6个月。由于采取了谨慎的预防措施,诊所继续进行治疗,没有受到污染。
{"title":"Radiotherapy in Cancer Treatment During The Covid-19 Pandemic: One Year Results From Northeast Turkey","authors":"Özlem Aynacı","doi":"10.5505/tjo.2022.3463","DOIUrl":"https://doi.org/10.5505/tjo.2022.3463","url":null,"abstract":"OBJECTIVE The goal of this article was to assess the effects and consequences of strict measures in radiation oncology centers in northeastern Turkey during the coronavirus disease-2019 pandemic and to ensure that the reorganization of programs occurred without interruption to radiotherapy (RT). METHODS We retrospectively reviewed the records of 1063 patients (median age 63 years;range 3-93 years) who were treated in RI centers from March 2020 to March 2021. The study cohort was divided into two groups: Group A consisted of patients who received RT in the first 6 months and Group B comprised patients who received RT in the second 6 months. RESULTS The age distribution was similar in both groups. The analysis of the intent of treatment showed that 585 (55%) patients were treated with a radical intent in Group A, whereas only 478 (45%) were treated with a radical intent in Group B. Lung, breast, and genitourinary cancers were the most common cancer types in both periods. There was a significant decline in the number of female patients in Group B. Test results of 31 (2.9%) patients, 8 (25.8%) women and 23 (74.2%) men, who had nasopharyngeal swabs, were positive. CONCLUSION This study shows that oncology patients in our region are more worried about disease progression than the pandemic and insist on going to RT, especially during the first 6-month period when the pandemic was thought to be temporary. As a result of careful precautions, treatments in the clinics continued without contamination.","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71125413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Survivin As an Immunohistochemical Prognostic Biomarker in Colorectal Cancer: A Meta-Analysis Survivin作为结直肠癌的免疫组织化学预后生物标志物:一项荟萃分析
IF 0.3 Q4 Medicine Pub Date : 2022-01-01 DOI: 10.5505/tjo.2022.3470
S. H. Aktas
{"title":"Survivin As an Immunohistochemical Prognostic Biomarker in Colorectal Cancer: A Meta-Analysis","authors":"S. H. Aktas","doi":"10.5505/tjo.2022.3470","DOIUrl":"https://doi.org/10.5505/tjo.2022.3470","url":null,"abstract":"","PeriodicalId":42117,"journal":{"name":"Turk Onkoloji Dergisi-Turkish Journal of Oncology","volume":null,"pages":null},"PeriodicalIF":0.3,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71125561","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Turk Onkoloji Dergisi-Turkish Journal of Oncology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1